Recurrent Multiple Myeloma « Maryland Oncology HematologyFarydak® (panobinostat) Empliciti® (elotuzumab) IMiDs (immunomodulatory drugs)Kyprolis®(carfilzomib) Ninlaro® (ixazomib) Alkylating agents (chemotherapy)
